Coffee, Decaffeinated Coffee, and Tea Consumption Linked to Lower Diabetes Risk
|
By HospiMedica International staff writers Posted on 22 Dec 2009 |
High intakes of coffee, decaffeinated coffee, and tea are linked to a reduced risk of Type 2 Diabetes Mellitus, according to a pooled review of studies.
Researchers at the George Institute for International Health (Sydney, Australia), the University of Glasgow (United Kingdom), and other institutions conducted a systematic review and meta-analysis investigating the association among coffee, decaffeinated coffee, and tea consumption with the risk of diabetes mellitus. The meta-analysis included data obtained from 18 studies that reported on the association between coffee consumption and diabetes; six studies that reported estimates of the association between decaffeinated coffee and diabetes; and seven studies that reported on the association of tea.
The results of the pooled meta-analysis found that drinking coffee was inversely related to risk of diabetes (more coffee was linked to lower risk). After adjusting for potential confounders, every extra cup of coffee consumed in a day was linked to a 7% reduction in the excess risk of diabetes; drinking 3 to 4 cups per day was linked to a 25% lower risk than drinking none or up to two cups per day. In those studies that assessed decaffeinated coffee consumption, drinking more than 3 to 4 cups a day was linked to about one third lower risk of diabetes, compared to none. Drinking more than 3 to 4 cups of tea per day was linked to a one fifth lower risk of diabetes, compared to non-tea drinking. The authors suggested the effect of tea and coffee consumption on diabetes risk could be due to direct biological effects, since their apparent protective effect appears to be independent of potential confounding variables, and could partly be due to other compounds present in tea and coffee, such as magnesium, or antioxidants such as lignans or chlorogenic acids. The study was published in the December 14, 2009, issue of the Archives on Internal Medicine.
"If such beneficial effects were observed in interventional trials to be real, the implications for the millions of individuals who have diabetes mellitus, or who are at future risk of developing it, would be substantial,” concluded first author Rachel Huxley, M.D., of the George Institute, and colleagues. "It could also be envisaged that we will advise our patients most at risk for diabetes mellitus to increase their consumption of tea and coffee in addition to increasing their levels of physical activity and weight loss.”
Related Links:
George Institute for International Health
University of Glasgow
Researchers at the George Institute for International Health (Sydney, Australia), the University of Glasgow (United Kingdom), and other institutions conducted a systematic review and meta-analysis investigating the association among coffee, decaffeinated coffee, and tea consumption with the risk of diabetes mellitus. The meta-analysis included data obtained from 18 studies that reported on the association between coffee consumption and diabetes; six studies that reported estimates of the association between decaffeinated coffee and diabetes; and seven studies that reported on the association of tea.
The results of the pooled meta-analysis found that drinking coffee was inversely related to risk of diabetes (more coffee was linked to lower risk). After adjusting for potential confounders, every extra cup of coffee consumed in a day was linked to a 7% reduction in the excess risk of diabetes; drinking 3 to 4 cups per day was linked to a 25% lower risk than drinking none or up to two cups per day. In those studies that assessed decaffeinated coffee consumption, drinking more than 3 to 4 cups a day was linked to about one third lower risk of diabetes, compared to none. Drinking more than 3 to 4 cups of tea per day was linked to a one fifth lower risk of diabetes, compared to non-tea drinking. The authors suggested the effect of tea and coffee consumption on diabetes risk could be due to direct biological effects, since their apparent protective effect appears to be independent of potential confounding variables, and could partly be due to other compounds present in tea and coffee, such as magnesium, or antioxidants such as lignans or chlorogenic acids. The study was published in the December 14, 2009, issue of the Archives on Internal Medicine.
"If such beneficial effects were observed in interventional trials to be real, the implications for the millions of individuals who have diabetes mellitus, or who are at future risk of developing it, would be substantial,” concluded first author Rachel Huxley, M.D., of the George Institute, and colleagues. "It could also be envisaged that we will advise our patients most at risk for diabetes mellitus to increase their consumption of tea and coffee in addition to increasing their levels of physical activity and weight loss.”
Related Links:
George Institute for International Health
University of Glasgow
Latest Critical Care News
- Circuit-Free Smart Patch Uses Smartphone Camera to Monitor Pulse and Vessel Stiffness

- Chest Digital Twin Guides Light Therapy Dosing for Pneumonia
- Intraoperative Drug Combination Reduces Kidney Injury in Septic Shock Surgery
- Wirelessly Powered Implant Targets Excess Glucose in the Blood
- Noninvasive Brain-Computer Interface Enables Responses in Some Unresponsive ICU Patients
- U.S. Launch Expands Kidney Replacement Therapy Options With Integrated Anticoagulation
- Smart Medical Adhesive Patch Uses Heat to Enable Gentle Removal
- Real-Time Data Platform Supports Precision Care in Polycystic Kidney Disease
- Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk
- Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS
- Consumer Smartwatch May Expand Access to Obstructive Sleep Apnea Screening
- Proposed Risk Score Prioritizes Sickest Patients for Heart Transplant
- Wristwatch Sensor Tracks Sodium and Potassium in Sweat in Real Time
- Smart Tear Sensors May Help Detect Shifts in Eye Health Over Time
- Wearable Smart Ring Receives FDA Clearance for Noninvasive Blood Oxygen Monitoring
- AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies
Channels
Artificial Intelligence
view channel
AI Tool Improves Hospital Discharge Summaries to Support Follow-Up Care
Discharge summaries guide care after hospitalization but can be difficult to prepare after long or complex stays. Clinicians must condense treatment, medications, follow-up, and unresolved issues into... Read more
AI Tool Predicts Hypertensive Crisis Up to 72 Hours Ahead
A hypertensive crisis is a rapid and severe rise in blood pressure above 180/120 mm Hg accompanied by acute end-organ damage. It can lead to stroke, heart attack, kidney injury, aortic dissection, or pulmonary... Read moreSurgical Techniques
view channel
Dual-Technique Approach Improves Stent Expansion in Calcified Coronary Lesions
Calcified coronary nodules are hard, irregular calcium deposits that protrude into coronary arteries and can complicate percutaneous coronary intervention by preventing full stent expansion.... Read more
FDA Approves First Transcatheter Device for Paravalvular Leak Closure
Paravalvular leak is a backflow of blood around a surgical heart valve that can follow valve replacement, causing heart failure symptoms or hemolysis. These leaks occur in 7%–17% of mitral valve replacements... Read morePatient Care
view channel
Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more
Expert Review Outlines Diagnosis and Treatment of Recurrent Catheter Infections
Patients who rely on long-term intravenous catheters for chemotherapy, hemodialysis, intravenous nutrition, and other essential therapies remain at risk of catheter-related bloodstream infections.... Read moreMedical Imaging
view channel
Imaging Biomarker Links Breast Tumor Heterogeneity to Targeted Therapy Response
Breast cancer patients can respond differently to targeted therapy, even when their tumors appear similar on conventional imaging. This variability can expose some patients to treatments that provide limited... Read more
AI-Guided Echocardiography Enables Mobile Cardiac Imaging in Rural Communities
Echocardiography uses ultrasound to provide real-time images of cardiac structure and function, but access can be limited in rural communities where testing often depends on expert sonographers, imaging... Read more
Privacy-Preserving AI Tool Synthesizes CT for Radiation Therapy Planning
Radiation therapy planning depends on accurate medical imaging to calculate dose, visualize organs, and position patients during treatment. Hospitals need large imaging datasets to train robust artificial... Read more
Tissue Around Breast Microcalcifications Emerges as a Key Source of Diagnostic Information
Breast microcalcifications are small calcium deposits that are often detected on mammography and digital breast tomosynthesis. Clinicians use their morphology and distribution to assess suspicious breast... Read moreHealth IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read moreBusiness
view channel
Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal
Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Stryker Enters Soft-Tissue Robotics Through Strategic Alliance With CMR Surgical
Stryker (Portage, MI, USA) and CMR Surgical (Cambridge, UK) have announced a strategic alliance centered on the Versius Surgical Robotic portfolio. The agreement includes an approximately USD 400 million... Read more







